Better Coronavirus Stock: iBio vs. Vaxart
iBio Pharma (NYSEMKT: IBIO) and Vaxart (NASDAQ: VXRT) rank as two of the biggest winners so far this year among small-cap biotechs with coronavirus programs. Shares of iBio have skyrocketed more than 1,600% year to date, while Vaxart stock is up close to 2,500%.
Which of these coronavirus stocks is the better pick now? Here's how iBio and Vaxart stack up against each other.
Image source: Getty Images.
Source Fool.com
